ST. JOSEPH, Mich., Feb. 17 /PRNewswire/ -- GeneGo, Inc., the leading systems biology tools company, announced today that Millipore has licensed 250 manually curated pathway maps from GeneGo, Inc. for their new Interactive Biological Pathway Tool. Available at www.millipore.com/pathways, the tool links Millipore’s cutting edge antibodies, proteins, and assays as well as relevant bioinformatics content to related biological pathways. These maps have been categorized by diseases and cellular processes to make it easier to find relevant information.
“In many cases, discovering the mechanisms of disease and uncovering new drug targets requires an understanding of not just individual biological events, but key biological pathways,” said Siamak Baharloo, PhD, Director of eBusiness at Millipore. “This tool provides a relevant new interface to assist scientists in planning and executing their research within the context of the biological systems in which they are interested.”
When a researcher accesses a pathway map, they see a detailed description of the pathway and supporting literature references. As the researcher selects protein or gene targets along the pathway, information is dynamically populated into a Target Information Dashboard. The dashboard information includes the gene symbol and aliases; links to bioinformatics content and recent publications; as well as links to appropriate Millipore products.
“We are very pleased to see the Millipore site go live in record time and respect their dedication to high quality products and pathways to showcase them,” said Julie Bryant, VP of Business Development. “We look forward to a long term relationship with Millipore as they make valuable content and tools available to their customer base.”
GeneGo, Inc.
GeneGo, Inc. develops systems biology technology such as compound based pathway analysis, cheminformatics & bioinformatics software for life science research. The original computational MetaDiscovery(TM) platform allows an integration and expert analysis of different kinds of experimental data (mRNA expression, proteomics, metabolomics, microRNA assays and other phenotypic data) and relevant bioactive chemistry (metabolites, drugs, other xenobiotics) within the framework of curated biological pathways and networks. GeneGo’s flagship product, MetaCore 5.2(TM), assists pharmaceutical scientists in the areas of target selection and validation, data mining in biology, identification of biomarkers for disease states and toxicology. The second product, MetaDrug 5.2(TM) is designed for prediction of human metabolism, toxicity and biological effects for novel small molecules compounds. MetaBase(TM) represents the knowledge base for MetaCore.
For more information, please visit the company’s web site at www.genego.com.
About Millipore
Millipore is a Life Science leader providing cutting-edge technologies, tools, and services for bioscience research and biopharmaceutical manufacturing. As a strategic partner, we collaborate with customers to confront the world’s challenging human health issues. From research to development to production, our scientific expertise and innovative solutions help customers tackle their most complex problems and achieve their goals. Millipore Corporation is an S&P 500 company with 6,000 employees in 47 countries worldwide. For more information, please contact Millipore Tech Service at 1-800-548-7853 or 951-676-8080 or visit www.millipore.com.
CONTACT: Julie Bryant, VP Business Development and Marketing of GeneGo,
Inc., +1--858-756-7996, julie@genego.com
Web site: http://www.genego.com/
